Actuate Therapeutics Inc Statistics
Share Statistics
Actuate Therapeutics Inc has 19.62M
shares outstanding. The number of shares has increased by null%
in one year.
| Shares Outstanding | 19.62M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 2,351 |
| FTD / Avg. Volume | 4.63% |
Short Selling Information
The latest short interest is 198.28K, so 1.01% of the outstanding
shares have been sold short.
| Short Interest | 198.28K |
| Short % of Shares Out | 1.01% |
| Short % of Float | 3.24% |
| Short Ratio (days to cover) | 3.72 |
Valuation Ratios
The PE ratio is -2.44 and the forward
PE ratio is -7.97.
Actuate Therapeutics Inc's PEG ratio is
-0.03.
| PE Ratio | -2.44 |
| Forward PE | -7.97 |
| PS Ratio | 0 |
| Forward PS | 1.8 |
| PB Ratio | 639.69 |
| P/FCF Ratio | -3.05 |
| PEG Ratio | -0.03 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Actuate Therapeutics Inc.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.05,
with a Debt / Equity ratio of 0.
| Current Ratio | 1.05 |
| Quick Ratio | 1.05 |
| Debt / Equity | 0 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 1344.27 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-2,728,532.8 |
| Employee Count | 10 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 800 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by null% in the
last 52 weeks. The beta is 0.67, so Actuate Therapeutics Inc's
price volatility has been higher than the market average.
| Beta | 0.67 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 8.81 |
| 200-Day Moving Average | 8.27 |
| Relative Strength Index (RSI) | 67.91 |
| Average Volume (20 Days) | 50,724 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -25.16M |
| Net Income | -27.29M |
| EBITDA | -25.16M |
| EBIT | -27.3M |
| Earnings Per Share (EPS) | -3.26 |
Full Income StatementBalance Sheet
The company has 8.64M in cash and 0 in
debt, giving a net cash position of 8.64M.
| Cash & Cash Equivalents | 8.64M |
| Total Debt | n/a |
| Net Cash | n/a |
| Retained Earnings | -132.38M |
| Total Assets | 4.48M |
| Working Capital | -4.91M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -21.84M
and capital expenditures 0, giving a free cash flow of -21.84M.
| Operating Cash Flow | -21.84M |
| Capital Expenditures | n/a |
| Free Cash Flow | -21.84M |
| FCF Per Share | -2.61 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
